Targeting gene expression to hypoxic tumor cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9142119.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Solid tumors with areas of low oxygen tension (hypoxia) have a poor prognosis, as cells in this environment often survive radiation and chemotherapy. In this report we describe how this hypoxic environment can be used to activate heterologous gene expression driven by a hypoxia-responsive element (HRE), which interacts with the transcriptional complex hypoxia-inducible factor-1 (HIF-1). Our results demonstrate that the HIF-1/HRE system of gene regulation is active in hypoxic tumor cells and show the potential of exploiting tumor-specific conditions for the targeted expression of diagnostic or therapeutic genes in cancer therapy.
Medical subject headings
- DNA-Binding Proteins
- Fibrosarcoma
- Gene Expression Regulation, Neoplastic
- Nuclear Proteins
- Oxygen
- Phosphoglycerate Kinase
- Transcription Factors